CVE-2022-1067
MEDIUMCVSS 6.5/10EPSS 0.83%
Last modified
CVE-2022-1067 is a medium-severity vulnerability rated 6.5/10 on the CVSS scale. Navigating to a specific URL with a patient ID number will result in the server generating a PDF of a lab report without authentication and rate limiting.. EPSS estimates a 0.83% chance of exploitation in the next 30 days.
Description
Navigating to a specific URL with a patient ID number will result in the server generating a PDF of a lab report without authentication and rate limiting.
Metrics
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Lifepoint | Patient Portal | < lpi_3.5.12.p30 |
References
- https://www.cisa.gov/uscert/ics/advisories/icsma-22-095-01Third Party Advisory, US Government Resource
- https://www.cisa.gov/uscert/ics/advisories/icsma-22-095-01Third Party Advisory, US Government Resource
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2022-1067?
Navigating to a specific URL with a patient ID number will result in the server generating a PDF of a lab report without authentication and rate limiting.
How severe is CVE-2022-1067?
CVE-2022-1067 has a CVSS score of 6.5/10 (MEDIUM severity). The EPSS model estimates a 0.83% probability of exploitation in the next 30 days.
How do I fix CVE-2022-1067?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2022-1067?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST